CD138

CD138

CD138 Molekülinformation

Molecule Name
Syndecan-1
Molekülalias
CD138
Drug Development Progress
Anzahl der klinischen Arzneimittel1
Anzahl der inverkehr gebrachten Arzneimittel0
Höchste Forschungs- und EntwicklungsphasePhase 1 Clinical
Target-Alias
Syndecan Proteoglycan 1,CD138 Antigen,SYND1,SDC,Heparan Sulfate Proteoglycan Fibroblast Growth Factor Receptor,Syndecan,CD138,Syndecan-1,SDC1,Syndecan 1
Molekülhintergrund
Syndecan-1 (SYND1 or SDC1) is also known as CD antigen CD138, is a transmembrane (type I) heparan sulfate proteoglycan and is a member of the syndecan proteoglycan family. The syndecans mediate cell binding, cell signaling, and cytoskeletal organization and syndecan receptors are required for internalization of the HIV-1 tat protein. The syndecan-1 / SDC1 protein functions as an integral membrane protein and participates in cell proliferation, cell migration and cell-matrix interactions via its receptor for extracellular matrix proteins. It is a useful marker for plasma cells, but only if the cells tested are already known to be derived from blood.

CD138 Produktliste

Host Species
  • Rabbit(1)
Conjugate
  • Unconjugated(1)
Reactive Species
  • Human(1)
Applications
  • Flow Cyt(1)
MoleculeCat. No.Product NameHost SpeciesReactive SpeciesApplicationsSize&PriceAdd to Cart
CD138
Monoclonal Anti-CD138 Antibody, Rabbit IgG (P2G04)
Rabbit
Human
Flow

$55.00

25ug
You Have Viewed 1-1 Of 1 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

Asset Licensing Opportunity
Resources

Klinische Arzneimittelinformation

Englischer NameForschungscodeForschungsphaseFirmaIndikationenKlinische Studie
ATLCAR.CD138 (UNC Lineberger Comprehensive Cancer Center)Phase 1 ClinicalUnc Lineberger Comprehensive Cancer Center
Immune System Diseases; Multiple Myeloma
Details
Customer Reviews